丙泊酚及七氟醚对乳腺癌影响的研究进展
Advances in the Study of the Effects of Propofol and Sevoflurane on Breast Cancer
DOI: 10.12677/ACM.2023.13112399, PDF,   
作者: 王 超, 艾吾再力·阿吉艾科拜尔, 孙金辉：新疆医科大学第三临床医学院(附属肿瘤医院)，新疆 乌鲁木齐；张 冰*：新疆医科大学附属肿瘤医院麻醉科，新疆 乌鲁木齐
关键词: 乳腺癌；丙泊酚；七氟醚；麻醉药物；Breast Cancer； Propofol； Sevoflurane； Anaesthetic
摘要: 近年来，乳腺癌发病率逐渐升高，手术依旧是乳腺癌患者的重要治疗方法。手术的实施离不开麻醉的参与，麻醉药物对乳腺癌影响的相关研究也逐渐深入。丙泊酚和七氟醚分别是目前临床当中最常使用的静脉麻醉药和吸入麻醉药，研究发现二者可对乳腺癌患者围术期的治疗、生活质量产生重要影响。本文对乳腺癌发展相关机制及通路和麻醉药对乳腺癌发生发展的影响进行综述。
Abstract: The incidence of breast cancer has gradually increased in recent years, surgery remains an im-portant treatment for breast cancer patients. Surgery cannot be performed without the involve-ment of anaesthesia, and studies related to the effects of anaesthetic drugs on breast cancer are gradually gaining ground. Propofol and sevoflurane are the most commonly used intravenous an-aesthetics and inhalation anaesthetics, respectively, and have been found to have a significant im-pact on the perioperative treatment and quality of life of breast cancer patients. This paper pro-vides a review of the mechanisms and pathways associated with breast cancer development and the effects of anaesthetics on the development of breast cancer.
文章引用：王超, 艾吾再力·阿吉艾科拜尔, 孙金辉, 张冰. 丙泊酚及七氟醚对乳腺癌影响的研究进展[J]. 临床医学进展, 2023, 13(11): 17116-17122. https://doi.org/10.12677/ACM.2023.13112399

参考文献

[1] Holly, E., Elizabeth, D., Farah, M., et al. (2017) Breast Cancer Surgical Treatment Choices in Newfoundland and Labra-dor, Canada: Patient and Surgeon Perspectives. Journal of Public Health Research, 6, 867. [Google Scholar] [CrossRef] [PubMed]
[2] Hiller, J.G., Perry, N.J., Poulogiannis, G., et al. (2018) Perioperative Events Influence Cancer Recurrence Risk after Surgery. Nature Reviews Clinical Oncology, 15, 205-218. [Google Scholar] [CrossRef] [PubMed]
[3] Rafferty, E.A., Park, J.M., Philpotts, L.E., et al. (2013) Assessing Radiologist Performance Using Combined Digital Mammography and Breast Tomosynthesis Compared with Digital Mammography Alone: Results of a Multicenter, Multireader Trial. Radiology, 266, 104-113. [Google Scholar] [CrossRef] [PubMed]
[4] Tkachev, V., Goodell, S., Opipari, A.W., et al. (2015) Programmed Death-1 Controls T Cell Survival by Regulating Oxidative Metabolism. The Journal of Immunology, 194, 5789-5800. [Google Scholar] [CrossRef] [PubMed]
[5] Sarfstein, R., Nagaraj, K., Leroith, D., et al. (2019) Differential Ef-fects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells. Cells, 8, Article No. 1499. [Google Scholar] [CrossRef] [PubMed]
[6] Huang, Y.C., Pan, W., Li, H., et al. (2020) c-Jun NH2-Terminal Kinase Suppression Significantly Inhibits the Growth of Transplanted Breast Tumors in Mice. Journal of International Medical Research, 48. [Google Scholar] [CrossRef] [PubMed]
[7] Tian, T., Li, X. and Zhang, J. (2019) mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy. International Journal of Molecular Sciences, 20, 755. [Google Scholar] [CrossRef] [PubMed]
[8] Jiang, W., Rixiati, Y., Huang, H., et al. (2020) Asperolide A Prevents Bone Metastatic Breast Cancer via the PI3K/AKT/mTOR/c-Fos/NFATc1 Signaling Pathway. Cancer Medicine, 9, 8173-8185. [Google Scholar] [CrossRef] [PubMed]
[9] Casadevall, D., Hernández-Prat, A., García-Alonso, S., et al. (2022) mTOR Inhibition and T-DM1 in HER2-Positive Breast Cancer. Molecular Cancer Research, 20, 1108-1121. [Google Scholar] [CrossRef] 
[10] Manore, S.G., Doheny, D.L., Wong, G.L., et al. (2022) IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment. Frontiers in Oncology, 12, Article ID: 866014. [Google Scholar] [CrossRef] [PubMed]
[11] Khatib, A., Solaimuthu, B., Ben Yosef, M., et al. (2020) The Glutathione Peroxidase 8 (GPX8)/IL-6/STAT3 Axis Is Essential in Maintaining an Aggressive Breast Cancer Phe-notype. Proceedings of the National Academy of Sciences of the United States of America, 117, 21420-21431. [Google Scholar] [CrossRef] [PubMed]
[12] Song, X., Liu, Z. and Yu, Z. (2020) EGFR Promotes the Develop-ment of Triple Negative Breast Cancer through JAK/STAT3 Signaling. Cancer Management and Research, 12, 703-717. [Google Scholar] [CrossRef] 
[13] Cassinello, F., Prieto, I., Del Olmo, M., et al. (2015) Cancer Surgery: How May Anesthesia Influence Outcome? Journal of Clinical Anesthesia, 27, 262-272. [Google Scholar] [CrossRef] [PubMed]
[14] Zhang, N., Ng, A.S., Cai, S., et al. (2021) Novel Therapeutic Strategies: Targeting Epithelial-Mesenchymal Transition in Colorectal Cancer. The Lancet Oncology, 22, e358-e368. [Google Scholar] [CrossRef] 
[15] Shapiro, J., Jersky, J., Katzav, S., et al. (1981) Anesthetic Drugs Accelerate the Progression of Postoperative Metastases of Mouse Tumors. Journal of Clinical Investigation, 68, 678-685. [Google Scholar] [CrossRef] 
[16] Buckley, A., Mcquaid, S., Johnson, P., et al. (2014) Effect of Anaesthetic Technique on the Natural Killer Cell Anti-Tumour Activity of Serum from Women Undergoing Breast Can-cer Surgery: A Pilot Study. British Journal of Anaesthesia, 113, i56-i62. [Google Scholar] [CrossRef] [PubMed]
[17] Zhang, X., Li, F., Zheng, Y., et al. (2019) Propofol Reduced Mam-mosphere Formation of Breast Cancer Stem Cells via PD-L1/Nanog in Vitro. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 9078209. [Google Scholar] [CrossRef] [PubMed]
[18] Wang, X. and Liu, Y. (2020) PD-L1 Expression in Tumor Infiltrated Lymphocytes Predicts Survival in Triple-Negative Breast Cancer. Pathology—Research and Practice, 216, Article ID: 152802. [Google Scholar] [CrossRef] [PubMed]
[19] Meng, C., Song, L., Wang, J., et al. (2017) Propofol Induces Pro-liferation Partially via Downregulation of p53 Protein and Promotes Migration via Activation of the Nrf2 Pathway in Human Breast Cancer Cell Line MDA-MB-231. Oncology Reports, 37, 841-848. [Google Scholar] [CrossRef] [PubMed]
[20] Enlund, M., Berglund, A., Ahlstrand, R., et al. (2020) Survival after Primary Breast Cancer Surgery Following Propofol or Sevoflurane General Anesthesia—A Retrospective, Multicenter, Database Analysis of 6305 Swedish Patients. Acta Anaesthesiologica Scandinavica, 64, 1048-1054. [Google Scholar] [CrossRef] [PubMed]
[21] 康忠奎, 黄伟, 谢先丰, 等. 丙泊酚通过下调miR-135b表达抑制乳腺癌MDA-MB-231细胞增殖、侵袭和迁移的研究[J]. 中国临床药理学杂志, 2020, 36(15): 2261-2264.
[22] Du, Q., Zhang, X., Zhang, X., et al. (2019) Propofol Inhibits Proliferation and Epithelial-Mesenchymal Transition of MCF-7 Cells by Suppressing miR-21 Expression. Artificial Cells, Nanomedicine, and Biotechnology, 47, 1265-1271. [Google Scholar] [CrossRef] [PubMed]
[23] 吕春宇, 巩立国, 陈强, 等. 七氟醚通过Circ_001589/miR-588调控乳腺癌细胞活力与凋亡[J]. 中华内分泌外科杂志, 2021, 15(6): 651-656.
[24] Liu, J., Yang, L., Guo, X., et al. (2018) Sevoflurane Suppresses Proliferation by Upregulating microRNA-203 in Breast Cancer Cells. Molecular Medicine Reports, 18, 455-460. [Google Scholar] [CrossRef] [PubMed]
[25] Ecimovic, P., Mchugh, B., Murray, D., et al. (2013) Effects of Sevoflurane on Breast Cancer Cell Function in Vitro. Anticancer Re-search, 33, 4255-4260.
[26] Deng, X., Vipani, M., Liang, G., et al. (2020) Sevoflurane Modulates Breast Cancer Cell Survival via Modulation of Intracellular Calcium Homeostasis. BMC Anesthesiology, 20, Article No. 253. [Google Scholar] [CrossRef] [PubMed]
[27] 徐红萌, 张艳红, 邱东洁, 等. 异丙酚和七氟醚对人乳腺癌细胞转移能力的影响[J]. 中华麻醉学杂志, 2015, 35(10): 1248-1250.
[28] Enlund, M., Berglund, A., Andreasson, K., et al. (2014) The Choice of Anaesthetic—Sevoflurane or Propofol—and Outcome from Cancer Surgery: A Retrospective Analysis. Upsala Journal of Medical Sciences, 119, 251-261. [Google Scholar] [CrossRef] [PubMed]
[29] Lee, J.H., Kang, S.H., Kim, Y., et al. (2016) Effects of Propofol-Based Total Intravenous Anesthesia on Recurrence and Overall Survival in Patients after Modified Radical Mastectomy: A Retrospective Study. Korean Journal of Anesthesiology, 69, 126-132. [Google Scholar] [CrossRef] [PubMed]
[30] Enlund, M., Berglund, A., Enlund, A., et al. (2022) Volatile versus Propofol General Anesthesia and Long-Term Survival after Breast Cancer Surgery: A National Registry Retrospective Cohort Study. Anesthesiology, 137, 315-326. [Google Scholar] [CrossRef] 
[31] Looney, M., Doran, P. and Buggy, D.J. (2010) Effect of Anesthetic Technique on Serum Vascular Endothelial Growth Factor C and Transforming Growth Factor β in Women Undergoing Anesthesia and Surgery for Breast Cancer. Anesthesiology, 113, 1118-1125. [Google Scholar] [CrossRef] 
[32] Oh, C.S., Lee, J., Yoon, T.G., et al. (2018) Effect of Equi-potent Doses of Propofol versus Sevoflurane Anesthesia on Regulatory T Cells after Breast Cancer Surgery. Anesthesi-ology, 129, 921-931. [Google Scholar] [CrossRef] 
[33] Lim, J.A., Oh, C.S., Yoon, T.G., et al. (2018) The Effect of Propofol and Sevoflurane on Cancer Cell, Natural Killer Cell, and Cytotoxic T Lymphocyte Function in Patients Under-going Breast Cancer Surgery: An in Vitro Analysis. BMC Cancer, 18, Article No. 159. [Google Scholar] [CrossRef] [PubMed]
[34] Jaura, A.I., Flood, G., Gallagher, H.C., et al. (2014) Differential Effects of Serum from Patients Administered Distinct Anaesthetic Techniques on Apoptosis in Breast Cancer Cells in Vitro: A Pilot Study. British Journal of Anaesthesia, 113, i63-i67. [Google Scholar] [CrossRef] [PubMed]
[35] Tavare, A.N., Perry, N.J., Benzonana, L.L., et al. (2012) Cancer Recurrence after Surgery: Direct and Indirect Effects of Anes-thetic Agents. International Journal of Cancer, 130, 1237-1250. [Google Scholar] [CrossRef] [PubMed]
[36] Tanaka, T., Takabuchi, S., Nishi, K., et al. (2010) The Intravenous Anesthetic Propofol Inhibits Lipopolysaccharide-Induced Hypox-ia-Inducible Factor 1 Activation and Suppresses the Glucose Metabolism in Macrophages. Journal of Anesthesia, 24, 54-60. [Google Scholar] [CrossRef] [PubMed]
[37] Benzonana, L.L., Perry, N.J., Watts, H.R., et al. (2013) Isoflurane, a Commonly Used Volatile Anesthetic, Enhances Renal Cancer Growth and Malignant Potential via the Hy-poxia-Inducible Factor Cellular Signaling Pathway in Vitro. Anesthesiology, 119, 593-605. [Google Scholar] [CrossRef] 

为你推荐